Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung Cancer
- 19 December 2019
- journal article
- research article
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 75 (4), 223-230
- https://doi.org/10.1159/000504874
Abstract
Background: Cancer and aging are both frequently associated with malnutrition, a factor of poor prognosis. In adult cancer patients, this may be related in part to impaired energy metabolism, with higher than predicted resting energy expenditure (REE) in about 50% of patients. We hypothesized that frequently impaired energy metabolism in elderly patients could potentiate cancer-associated hypermetabolism, further promoting risk of malnutrition. Objective: To study the hypermetabolic response to cancer in a predominantly aged population and the potential underlying determinants. Methods: This was a cross-sectional exploratory study in patients with non-small-cell lung cancer. REE was measured by indirect calorimetry. Body composition was determined from a single CT scan imaging at L3 level. Endocrine, inflammatory, nutritional and metabolic status were evaluated. Results: Twenty-seven patients, of median age 68 years (range 32–81) completed the study. In this population, mean measured REE was 7.5% higher than calculated REE. Sex and weight accounted for about 51% of REE variations, whereas age accounted only for 4%. However, these parameters did not explain the REE-to-lean body mass (LBM) ratio variations, suggesting that they influenced REE only through their effect on LBM. Among the other parameters evaluated, only the thyroid-stimulating hormone and interleukin-6 plasma levels appeared to have an influence on REE. The study of the consequences of this increase in REE-to-LBM ratio showed a growing inability of patients to meet their energy needs but showed no effect on nutritional markers such as transthyretin. Conclusions: The results of this pilot study suggest that in our population, age was not an important factor of REE. The elevated energy metabolism was associated with patients’ failure to increase their energy intakes sufficiently, which can contribute to the development of cachexia. Clinical Trial: This trial is registered at clinicaltrials.gov under NCT0314.Keywords
This publication has 23 references indexed in Scilit:
- Tryptophan-Degrading Enzymes in Tumoral Immune ResistanceFrontiers in Immunology, 2015
- Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosisAnnals of Oncology, 2015
- Energy Metabolism and the Burden of Multimorbidity in Older Adults: Results From the Baltimore Longitudinal Study of AgingThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2014
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan DepletionCancer Research, 2012
- Older age, poor performance status and major comorbiditiesCurrent Opinion in Oncology, 2012
- Mitochondrial energy metabolism and ageingBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine careApplied Physiology, Nutrition, and Metabolism, 2008
- The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and ProliferationCell Metabolism, 2008
- The mitochondrial energy transduction system and the aging processAmerican Journal of Physiology-Cell Physiology, 2007
- GCN2 Kinase in T Cells Mediates Proliferative Arrest and Anergy Induction in Response to Indoleamine 2,3-DioxygenaseImmunity, 2005